Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.28 - $0.65 $104,298 - $242,121
-372,495 Reduced 5.83%
6,018,211 $1.75 Million
Q2 2023

Aug 14, 2023

SELL
$0.49 - $0.82 $258,313 - $432,279
-527,170 Reduced 7.62%
6,390,706 $3.51 Million
Q1 2023

May 15, 2023

SELL
$0.65 - $1.1 $682,617 - $1.16 Million
-1,050,180 Reduced 13.18%
6,917,876 $5.67 Million
Q4 2022

Feb 14, 2023

SELL
$0.48 - $13.5 $141,598 - $3.98 Million
-294,996 Reduced 3.57%
7,968,056 $5.26 Million
Q3 2022

Nov 10, 2022

SELL
$0.79 - $22.0 $391,520 - $10.9 Million
-495,596 Reduced 5.66%
8,263,052 $7.11 Million
Q2 2022

Aug 15, 2022

SELL
$0.8 - $1.5 $67,101 - $125,815
-83,877 Reduced 0.95%
8,758,648 $7.36 Million
Q1 2022

May 13, 2022

SELL
$1.24 - $2.75 $301,915 - $669,570
-243,480 Reduced 2.68%
8,842,525 $12 Million
Q4 2021

Feb 14, 2022

BUY
$2.42 - $3.65 $2.29 Million - $3.45 Million
945,211 Added 11.61%
9,086,005 $22.7 Million
Q3 2021

Nov 15, 2021

BUY
$2.82 - $3.7 $1.72 Million - $2.26 Million
611,625 Added 8.12%
8,140,794 $26.2 Million
Q2 2021

Aug 16, 2021

SELL
$3.5 - $5.48 $3.76 Million - $5.88 Million
-1,073,524 Reduced 12.48%
7,529,169 $26.9 Million
Q1 2021

May 14, 2021

SELL
$3.16 - $4.89 $247,162 - $382,476
-78,216 Reduced 0.9%
8,602,693 $30.4 Million
Q4 2020

Feb 16, 2021

BUY
$2.2 - $4.45 $1 Million - $2.03 Million
455,971 Added 5.54%
8,680,909 $27.5 Million
Q3 2020

Nov 16, 2020

BUY
$2.62 - $4.78 $9.96 Million - $18.2 Million
3,800,000 Added 85.88%
8,224,938 $33.2 Million
Q2 2020

Aug 14, 2020

BUY
$1.83 - $3.16 $4.75 Million - $8.2 Million
2,596,138 Added 141.96%
4,424,938 $11.9 Million
Q1 2020

May 14, 2020

BUY
$1.14 - $2.96 $1.62 Million - $4.21 Million
1,421,592 Added 349.11%
1,828,800 $3.46 Million
Q4 2019

Feb 14, 2020

BUY
$1.25 - $2.57 $88,233 - $181,408
70,587 Added 20.97%
407,208 $1.05 Million
Q3 2019

Nov 14, 2019

BUY
$1.26 - $1.96 $424,142 - $659,777
336,621 New
336,621 $475,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $169M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.